Your browser doesn't support javascript.
loading
Clinical Efficacy of Nalmefene for Chronic Type Ⅱ Respiratory Failure / 中国药房
China Pharmacy ; (12)1991.
Article de Zh | WPRIM | ID: wpr-533521
Bibliothèque responsable: WPRO
ABSTRACT
OBJECTIVE: To study the clinical efficacy of Nalmefene in the treatment of chronic type Ⅱrespiratory failure. METHODS: A total of 40 patients with chronic type Ⅱ respiratory failure were randomly divided into treatment group and the control group: the treatment group received Nalmefene (1.0 mg) plus 5% GS (250 mL) q.d by iv gtt. in addition to the routine treatment, and the control group received 1.875 g Nikethamide plus 5% GS (250 mL) q.d by iv gtt. After 5-day treatment, the clinical symptom, physical signs, adverse drug reactions, lung function testing and blood gas analysis in two groups were evaluated. RESULTS: The overall response rate was 95.0% in the treatment group vs. 60.0% in the control group(P
Mots clés
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: China Pharmacy Année: 1991 Type: Article
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: China Pharmacy Année: 1991 Type: Article